ERBB2 and aneurysmal bone cyst: Endocrine therapy (ET) is an effective treatment in hormone receptor (HR) positive HER2 negative advanced breast cancer (ABC), even if approximately 50% of patients develop resistance to anti-estrogen therapy within their lifetime (2).